M. Rothe

发表

The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation.

D. Goeddel, H. Y. Song, M. Rothe, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes*

M. Rothe, A. Mantovani, M. Arditi, 1999, The Journal of Biological Chemistry.

Three hormone receptor‐like Drosophila genes encode an identical DNA‐binding finger.

U. Nauber, H. Jäckle, M. Rothe, 1989, The EMBO journal.

Loss of gene function through rapid mitotic cycles in the Drosophila embryo

Mike Rothe, H. Jäckle, M. Pehl, 1992, Nature.

Redundant functions of the genes knirps and knirps-related for the establishment of anterior Drosophila head structures.

H. Jäckle, M. Gonzalez-Gaitan, M. Rothe, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Identical transacting factor requirement for knirps and knirps-related gene expression in the anterior but not in the posterior region of the Drosophila embryo

Mike Rothe, Michael J. Pankratz, Marcos González-Gaitán, 1994, Mechanisms of Development.

The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins

Mike Rothe, T. Ayres, D. Goeddel, 1995, Cell.

Inhibitors of apoptosis

D. Goeddel, M. Rothe, 1997 .

Identical transacting factor requirement for knirps and knirps-related gene expression in the anterior but not in the posterior region of the Drosophila embryo

H. Jäckle, M. Pankratz, M. Gonzalez-Gaitan, 1994, Mechanisms of Development.

Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.

E. Smeland, D. Goeddel, S. Jacobsen, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Responding to Endotoxin for Toll-Like Receptor 2 Are Capable of Cutting Edge: Cells That Carry A Null Allele

D. Golenbock, M. Rothe, H. Heine, 2013 .

Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2*

M. Rothe, R. Dziarski, C. Kirschning, 1999, The Journal of Biological Chemistry.

IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK

Mike Rothe, Zhaodan Cao, D. Goeddel, 1997 .

Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity.

L. Pardo, W. Stühmer, M. Rothe, 2007, Cancer research.

Identification and characterization of an IkappaB kinase.

D. Goeddel, Z. Cao, H. Y. Song, 1997, Cell.

Identification and Characterization of an IκB Kinase

D. Goeddel, Z. Cao, M. Rothe, 1997, Cell.

Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide

M. Rothe, C. Kirschning, H. Wesche, 1998, The Journal of experimental medicine.

DNA-Binding Proteins in Drosophila Development

H. Jäckle, M. Pankratz, M. Hoch, 1990 .

Fully human Anti-HER3 monoclonal antibodies (mAbs) have unique in vitro and in vivo functional and antitumor activities versus other HER family inhibitors

Daniel J. Freeman, M. Rothe, R. Radinsky, 2008 .

Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor

Mike Rothe, L. Tartaglia, D. Goeddel, 1993, Cell.

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

D. Goeddel, V. Dixit, D. Goeddel, 1995, Science.

Cutting edge: cells that carry A null allele for toll-like receptor 2 are capable of responding to endotoxin.

B. Monks, D. Golenbock, M. Rothe, 1999, Journal of immunology.

Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.

D. Goeddel, T. Mak, D. Speiser, 1997, Immunity.

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.

D. Goeddel, Z. Cao, M. Rothe, 1997, Science.

Anatomy of TRAF2

D. Goeddel, M. Rothe, M. Takeuchi, 1996, The Journal of Biological Chemistry.

Identification of MMP-15 as an Anti-apoptotic Factor in Cancer Cells*

J. Schäfer, A. Ullrich, M. Rothe, 2005, Journal of Biological Chemistry.

Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins

Hedi Peterson, Jaak Vilo, Mike Rothe, 2017, Front. Immunol..

I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.

D. Goeddel, A. Goddard, H. Shu, 1996, Proceedings of the National Academy of Sciences of the United States of America.

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

D. Goeddel, M. Rothe, W. Henzel, 1994, Cell.

Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2.

D. Goeddel, M. Rothe, C. Kirschning, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Activation of NF-кB By Inflammatory Cytokines

M. Rothe, 1999 .

Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1*

T. Ayres, S. Marsters, M. Skubatch, 1997, The Journal of Biological Chemistry.

309 POSTER Fully human anti-HER3 mAb U3-1287 (AMG 888) demonstrates unique in vitro and in vivo activities versus other HER family inhibitors in NSCLC models

Daniel J. Freeman, M. Rothe, R. Radinsky, 2008 .

Fully human Anti-HER3 monoclonal antibodies (mAbs) inhibit oncogenic signaling and tumor cell growth in vitro and in vivo

Daniel J. Freeman, S. Hartmann, M. Rothe, 2008 .

NF-kappa B activation by tumor necrosis factor and interleukin-1.

D. Goeddel, Z. Cao, M. Rothe, 1999, Cold Spring Harbor symposia on quantitative biology.

ASK1 is essential for JNK/SAPK activation by TRAF2.

K. Miyazono, M. Rothe, H. Nakano, 1998, Molecular cell.

Components of a Stat recognition code: evidence for two layers of molecular selectivity.

S. McKnight, M. Rothe, U. Schindler, 1995, Immunity.